Spasticity, as a common effect of damage to the central nervous system, occurs in strokes and all types of traumatic or non-traumatic damage (brain and spinal cord).
The consequence is involuntary overactivity of the muscles, with detrimental effects such as pain, fixed joint dislocation and impaired functions. Treatment using traditional physiotherapy and antispastic medication (oral administration) is limited in cases of severe progression of the disorder.
Our special consultations offer the possibility of testing indications for other methods in an interdisciplinary manner and introducing corresponding therapeutic measures.
Of primary importance are:
Outpatient treatment using botulinum toxin for the following
- Improving and facilitating motor functions (ability to walk and sit, active use of the hands or arms)
- Ease of transfer (e.g. bed to wheelchair)
- Pain reduction
- Improved care
- Prophylaxis of secondary complications (contractures; decubitus). Primary application in cases of focal (progressive) spasticity
Intrathecal therapy ITB (antispastic medication via special pump near the spinal cord) for the following
- Improving motor functions in the lower extremities by influencing multi-segmental (para-)spasticity
- Improvement of basic care
- Decubital prophylaxis
Oral antispastic medication with cannabinoids
Counselling and support for:
- Purchasing and administering medication
- Outpatient monitoring